Spring direct naar de hoofdnavigatie of de inhoud

Blijke Kroezen

Patent attorney

‘Innovation is the process of turning ideas into manufacturable and marketable form. (Watts Humprey)’
Blijke Kroezen

Blijke Kroezen

  • Life Sciences
  • Trainee Patent Attorney

Blijke Kroezen studied chemistry at the university of Groningen. For her Master’s research she worked on the development of novel medicines for malaria and tuberculosis. She was primarily responsible for the organic synthesis of the molecules, but was also involved in the design of the scaffolds using molecular modelling tools and the development of new in vitro assays to determine the affinity of the molecules.

Continue reading

She particularly enjoyed the multidisciplinary character of the research project and therefore decided in 2013 to pursue a PhD at the Faculty of Pharmaceutical Sciences at the University of Basel. During her PhD she started a new research project on the development of novel medicines for asthma. For four years, she specialized primarily in the design and synthesis of carbohydrates and carbohydrate-mimetics. In 2017, she obtained her PhD summa cum laude and in the same year she started as a trainee patent attorney at V.O.

Education

  • MSc in Chemistry, University of Groningen (2012)
  • PhD in Pharmaceutical Sciences, University of Basel (2017)

Publications

  • Masini, T., Pilger, J., Kroezen, B. S., Illarionov, B., Lottmann, P., Fischer, M., Griesinger C. and Hirsch, A. K. H., Chemical Science, 2014, 5, 3543-3551.
  • Masini, T., Kroezen, B.S., Hirsch, A.K.H., Drug Discovery Today, 2013, 18, 1256-1262.

Languages

  • Dutch
  • English
  • German

 

Also see these experts

Marijke Westra

Marijke Westra

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
Jetze Beeksma

Jetze Beeksma

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
More experts

News

New on Kluwer Patent Blog: Bayer Intellectual Property GmbH vs. Ceva Santé Animale SA, Nederland

Bayer was not granted an injunction in preliminary proceedings because the Court found that there was a serious chance that Bayer’s patent would be held invalid.Continue reading

New on Kluwer Patent Blog: Recordati Ireland Limited, EPO

A claim defining a compound as having a certain purity would lack novelty over a prior art disclosure describing the same compound only if the prior art disclosed the claimed purity at least implicitly.Continue reading

New on Kluwer Patent Blog: R-Pharm International, LLC, EPO

A request for re-establishment should be filed within two months of the date of removal of non-compliance.Continue reading

Events

Innovation for Health 2020

World Trade Center (WTC) Rotterdam, Beursplein, Rotterdam

Innovation for Health is the premier event for key players in Health & Life Sciences in the Netherlands and Belgium. It provides a unique opportunity to meet leading innovators, to catch up on the latest trends, to present cutting-edge innovations and to engage leaders and decision makers in Life Sciences & Health. Continue reading

2nd LIFE-ON-CHIP Conference 2020

Provincie Vlaams-Brabant - Provinciehuis Leuven, Provincieplein, Leuven, Belgium

Micro- and nanotechnology, artificial intelligence, design thinking, robotics, novel manufacturing technologies and big data have made major impacts across all industries, but perhaps their greatest potential impact will be in health and life sciences. Continue reading

MIP International Patent Forum 2020

etc.venues St Paul's, London, UK

As MIP’s flagship event, over 300 IP counsel register every year, connecting senior patent counsel with their peers from across Europe, Asia and the Americas. Join this event to expand your international business network. Continue reading